Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peritoneal flaps for the prevention of lymphoceles after robot-assisted radical prostatectomy-a systematic review and IPD-meta-analysis of randomized controlled trials.

World journal of urology·2026
Same author

A validation study of the in vitro performance of hypoxic red blood cells for transfusion across centers in Europe.

Transfusion·2025
Same author

Robotic-assisted super-extended pelvic lymph node dissection for prostate cancer: safety and pathologic findings.

The Canadian journal of urology·2025
Same author

Neurophysiology of Perceptual Decision-Making and Its Alterations in Attention-Deficit Hyperactivity Disorder.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2025
Same author

Transperineal Magnetic Resonance Imaging-Fusion Targeted Prostate Biopsy Utilizing the PrecisionPoint Transperineal Access System vs a Grid Template: An Assessment of Outcomes.

Urology·2025
Same author

Development, Implementation, and Impact of an Electronic Medical Record Alert System for Implanted Artificial Urinary Sphincters.

Urology practice·2025

Related Experiment Video

Updated: Jun 20, 2026

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells
06:24

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells

Published on: October 20, 2023

Optimizing mesenchymal stem cell-based therapeutics.

Joseph Wagner1, Thomas Kean, Randell Young

  • 1Cell Targeting, Inc., 11000 Cedar Ave., Cleveland, OH 44106, USA.

Current Opinion in Biotechnology
|September 29, 2009
PubMed
Summary
This summary is machine-generated.

Mesenchymal stem cell (MSC) therapeutics show promise in clinical trials, but commercialization faces hurdles. Strategies to enhance MSC potency and delivery are being explored, each with unique benefits and drawbacks for clinical utility.

More Related Videos

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)
06:20

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)

Published on: December 24, 2015

Related Experiment Videos

Last Updated: Jun 20, 2026

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells
06:24

Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells

Published on: October 20, 2023

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)
06:20

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)

Published on: December 24, 2015

Area of Science:

  • Regenerative Medicine
  • Biotechnology
  • Cell Therapy

Background:

  • Mesenchymal stem cell (MSC)-based therapeutics demonstrate significant clinical trial benefits.
  • Large-scale commercialization of MSC therapies faces persistent obstacles.
  • Optimizing MSC therapeutics is crucial for clinical and commercial success.

Purpose of the Study:

  • To review strategies for enhancing Mesenchymal stem cell (MSC) therapeutic potency.
  • To examine methods for improving MSC delivery to target tissues.
  • To evaluate the advantages and disadvantages of these strategies for commercialization.

Main Methods:

  • Investigated approaches for enhancing Mesenchymal stem cell (MSC) potency, including genetic modification and in vitro treatments.
  • Reviewed strategies to improve Mesenchymal stem cell (MSC) delivery, focusing on tissue-specific targeting.
  • Analyzed preclinical animal model data for efficacy and potential clinical utility.

Main Results:

  • Overexpression of trophic factors and in vitro potency enhancement show success in preclinical models.
  • Tissue-specific cytokine pathways and binding sites show promise for improved Mesenchymal stem cell (MSC) delivery.
  • Each optimization strategy presents distinct pros and cons for commercial viability.

Conclusions:

  • Enhancing Mesenchymal stem cell (MSC) potency and delivery are key areas of research for therapeutic advancement.
  • Careful consideration of advantages and disadvantages is necessary for successful commercial implementation.
  • Further development is needed to overcome obstacles in large-scale Mesenchymal stem cell (MSC) therapy commercialization.